| scholarly article | Q13442814 |
| P50 | author | Suzanne Marie Garland | Q87258284 |
| Julia M L Brotherton | Q87723655 | ||
| Sepehr N Tabrizi | Q87723657 | ||
| P2860 | cites work | Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. | Q54595028 |
| Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients. | Q54707057 | ||
| HPV infection in Europe | Q58280584 | ||
| Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests | Q58281465 | ||
| Laser capture microdissection technology | Q28250373 | ||
| Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women | Q28251260 | ||
| Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial | Q31151637 | ||
| Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3 | Q33984185 | ||
| Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England | Q34005902 | ||
| Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program | Q34017208 | ||
| Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence | Q34176414 | ||
| Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women | Q34959801 | ||
| Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California | Q35051454 | ||
| Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population | Q35587254 | ||
| Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. | Q35913775 | ||
| Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer | Q36128026 | ||
| Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis | Q36670753 | ||
| Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections | Q36994715 | ||
| Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States | Q37147012 | ||
| Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma | Q37484683 | ||
| Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. | Q37586279 | ||
| Temporal trends over 3 decades and intrafamilial clustering of HPV types in Swedish patients with cervical cancer in situ | Q38420657 | ||
| Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women | Q38443472 | ||
| Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. | Q40227526 | ||
| Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women | Q43655015 | ||
| Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer | Q44641247 | ||
| Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. | Q50547990 | ||
| The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. | Q51968734 | ||
| Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women. | Q54427886 | ||
| P433 | issue | 2 | |
| P921 | main subject | cervical intraepithelial neoplasia | Q196788 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 193-199 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Future Microbiology | Q15759961 |
| P1476 | title | Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance | |
| P478 | volume | 7 |
| Q34746231 | Correlation of cervical smear and pathohistological findings |
| Q55262571 | Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia. |
| Q30251868 | Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines |
| Q34157209 | HPV catch-up vaccination of young women: a systematic review and meta-analysis |
| Q98183609 | HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination |
| Q34987731 | Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study |
| Q30682187 | Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study |
| Q36251151 | Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia |
| Q34736619 | Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing |
| Q34622565 | Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany |
| Q44701708 | Reply to Ryser et al. |
| Q40412473 | Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women |
Search more.